Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Foxa1 and Foxa2 regulate bile duct development in mice
Zhaoyu Li, … , Sara Sackett, Klaus H. Kaestner
Zhaoyu Li, … , Sara Sackett, Klaus H. Kaestner
Published May 11, 2009
Citation Information: J Clin Invest. 2009;119(6):1537-1545. https://doi.org/10.1172/JCI38201.
View: Text | PDF
Research Article Hepatology

Foxa1 and Foxa2 regulate bile duct development in mice

  • Text
  • PDF
Abstract

The forkhead box proteins A1 and A2 (Foxa1 and Foxa2) are transcription factors with critical roles in establishing the developmental competence of the foregut endoderm and in initiating liver specification. Using conditional gene ablation during a later phase of liver development, we show here that deletion of both Foxa1 and Foxa2 (Foxa1/2) in the embryonic liver caused hyperplasia of the biliary tree. Abnormal bile duct formation in Foxa1/2-deficient liver was due, at least in part, to activation of IL-6 expression, a proliferative signal for cholangiocytes. The glucocorticoid receptor is a negative regulator of IL-6 transcription; in the absence of Foxa1/2, the glucocorticoid receptor failed to bind to the IL-6 promoter, causing enhanced IL-6 expression. Thus, after liver specification, Foxa1/2 are required for normal bile duct development through prevention of excess cholangiocyte proliferation. Our data suggest that Foxa1/2 function as terminators of bile duct expansion in the adult liver through inhibition of IL-6 expression.

Authors

Zhaoyu Li, Peter White, Geetu Tuteja, Nir Rubins, Sara Sackett, Klaus H. Kaestner

×

Figure 3

Hepatic deficiency of Foxa1/2 results in bile duct hyperplasia.

Options: View larger image (or click on image) Download as PowerPoint
Hepatic deficiency of Foxa1/2 results in bile duct hyperplasia.
(A) Immu...
(A) Immunohistochemical staining of paraffin-embedded liver sections from 3-month-old Foxa1loxP/loxPFoxa2loxP/loxP and Foxa1loxP/loxPFoxa2loxP/loxPAlfpCre mice with anti-CK19 antibody. Scale bar: 50 μm. Original magnification of insets, ×400. (B) Immunohistochemical staining of paraffin-embedded liver sections from 3-month-old mutant adult mice with anti-CK19 antibody. Scale bar: 50 μm. (C) Ultrastructure of bile ducts in adult control and mutant mice as determined by transmission EM analysis. Scale bars: 2 μm. (D) Immunofluorescent staining of proliferating cells in OCT-embedded liver sections from 3-month-old control and mutant mice. Mice were injected with BrdU 1 hour before sacrifice to label cells in S phase. BrdU-positive nuclei are shown in red; cholangiocytes were labeled with anti-CK19 antibody (green). Arrows point to BrdU-positive cholangiocytes. Original magnification, ×200.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts